Is Mereo BioPharma Group plc – ADR (MREO) a Leader in the Biotechnology
Mereo BioPharma Group plc – ADR (MREO) is near the top in its industry group according to InvestorsObserver. MREO gets an overall rating of 73. That means it scores higher than 73 percent of stocks. Mereo BioPharma Group plc – ADR gets a 98 rank in the Biotechnology industry. Biotechnology is number 88 out of 148 industries.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 73 means the stock is more attractive than 73 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What’s Happening With Mereo BioPharma Group plc – ADR Stock Today?
Mereo BioPharma Group plc – ADR (MREO) stock is trading at $3.65 as of 9:53 AM on Monday, Apr 5, a gain of $0.27, or 7.99% from the previous closing price of $3.38. The stock has traded between $3.60 and $3.76 so far today. Volume today is light. So far 510,241 shares have traded compared to average volume of 2,987,665 shares.